Viatris (VTRS) Treasury Shares (2019 - 2026)
Viatris' (VTRS) quarterly Treasury Shares came in at $1.0 billion in Q1 2026, up 48.15% year-on-year from $679.8 million in Q1 2025, and little changed quarter-over-quarter from $1.0 billion in Q4 2025.
Viatris (VTRS) Treasury Shares (2019 - 2026) Analysis & Trends
Viatris' Treasury Shares history runs 5 years deep, the most recent figure standing at $1.0 billion for Q1 2026.
- On a quarterly basis, Treasury Shares rose 48.15% year-over-year to $1.0 billion in Q1 2026; TTM through Mar 2026 was $1.0 billion, a 48.15% increase from a year earlier, with the FY2025 full-year figure at $1.0 billion, up 99.72% from the prior year.
- Treasury Shares steadied at $1.0 billion in Q1 2026 per VTRS's latest filing, from $1.0 billion in the prior quarter.
- Across five years, Treasury Shares topped out at $24.6 million in Q4 2019 and bottomed at $18.1 million in Q2 2021.
- The 3-year median for Treasury Shares is $21.7 million (2019), against an average of $21.5 million.
- Across the five-year window, Treasury Shares surged 100.28% in 2024 and surged 34.8% in 2025, its largest moves.
- Year by year, Treasury Shares stood at $251.8 million in 2023, then jumped by 100.28% to $504.3 million in 2024, then surged by 99.72% to $1.0 billion in 2025, then declined by 0.01% to $1.0 billion in 2026.
- Per Business Quant, the three latest VTRS Treasury Shares figures stand at $1.0 billion (Q1 2026), $1.0 billion (Q4 2025), and $924.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 62.52 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 107.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.29 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 313.27 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 5.44 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 59.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.01 Bn |
| Mar 31, 2026 | 1.01 Bn |
| Dec 31, 2025 | 1.01 Bn |
| Dec 31, 2025 | 1.01 Bn |
| Sep 30, 2025 | 924.20 Mn |
| Sep 30, 2025 | 924.20 Mn |
| Jun 30, 2025 | 855.80 Mn |
| Jun 30, 2025 | 855.80 Mn |
| Mar 31, 2025 | 679.80 Mn |
| Mar 31, 2025 | 679.80 Mn |
| Dec 31, 2024 | 504.30 Mn |
| Dec 31, 2024 | 504.30 Mn |
| Sep 30, 2024 | 504.30 Mn |
| Sep 30, 2024 | 504.30 Mn |
| Jun 30, 2024 | 504.30 Mn |
| Jun 30, 2024 | 504.30 Mn |
| Mar 31, 2024 | 504.30 Mn |
| Mar 31, 2024 | 504.30 Mn |
| Dec 31, 2023 | 251.80 Mn |
| Dec 31, 2023 | 251.80 Mn |